First Generic Teriparatide: Structural and Biological Sameness to Its Reference Medicinal Product

First Generic Teriparatide: Structural and Biological Sameness to Its Reference Medicinal Product

Teriparatide is an anabolic peptide drug indicated for the treatment of osteoporosis. Recombinant teriparatide was first approved in 2002 and has since been followed by patent-free alternatives under biosimilar or hybrid regulatory application. The aim of this study is to demonstrate the essential s...

Full description

Saved in:
Bibliographic Details
Main Authors: Jimena Fernández-Carneado (Author), Mariona Vallès-Miret (Author), Sílvia Arrastia-Casado (Author), Ana Almazán-Moga (Author), Maria J. Macias (Author), Pau Martin-Malpartida (Author), Marta Vilaseca (Author), Mireia Díaz-Lobo (Author), Mayte Vazquez (Author), Rosa M. Sanahuja (Author), Gemma Gambús (Author), Berta Ponsati (Author)
Format: Book
Published: MDPI AG, 2024-04-01T00:00:00Z.
Subjects:
article
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available

Similar Items